Home
Interesting shortcuts
EFFRA Members' Perspectives
News Dashboard
Projects
Projects
Results, demos etc.
Results, demos etc.
Structured Wiki
Search
FoF and Made in Europe Partnership
Demonstrators, pilots, prototypes
Exploitable result(s)
Significant innovations and lessons learned, training aspects
Report - Video - Presentation - Publication....?
Project clusters
Company perspectives
Manufacturing future products
Manufacturing performance characteristics
Technologies and enablers
ICT performance characteristics
Standards and standardisation
Contribution of R&I projects to standardisation
Regulatory and policy aspects
Standards - other classifications
Business model aspects
Pathways
MiE SRIA R&I Priorities
MiE 25-27 Priorities (public consultation)
MiE KPIs
Relevant open calls
EU-Programme-Call
NACE code
EFFRA Organisations - members
EFFRA WG pointers
Pathways
Pathways
Project ideas
Project ideas
People & organisations
People
Organisations
portal@effra.eu
Visit the EFFRA website
Login
Projects
Mesomorph
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.7. Innovative Medicines Initiative 2 (IMI2)
H2020-EU.3.1.7.0. Cross-cutting call topics
H2020-JTI-IMI2-2019-18-two-stage
Mesomorph
mapped on
H2020-JTI-IMI2-2019-18-two-stage
IMI2-2019-18-01 Central repository of digital pathology slides to support the development of artificial intelligence tools
IMI2-2019-18-02 Health Outcomes Observatories – empower patients with tools to measure their outcomes in a standardised manner creating transparency of health outcomes
IMI2-2019-18-03 Improving patient access, understanding and adherence to healthcare information: an integrated digital health information project
IMI2-2019-18-04 Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials
IMI2-2019-18-05 Accelerating research & innovation for advanced therapy medicinal products
IMI2-2019-18-06 Supporting the development of engineered T cells